- Accueil >
- Publications >
- [18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab
1 nov. 2023European Journal of Nuclear Medicine and Molecular Imaging
Auteurs
Romain-David Seban, Emilie Arnaud, Delphine Loirat, Luc Cabel, Paul Cottu, Lounes Djerroudi, Segolene Hescot, Pierre Loap, Claire Bonneau, Francois-Clement Bidard, Virginie Huchet, Nina Jehanno, Arnaud Berenbaum, Laurence Champion, Irene Buvat
Equipes
Membres